RAF dimer inhibitor lifirafenib enhances the antitumor activity of MEK inhibitor mirdametinib in RAS mutant tumors Meeting Abstract


Authors: Yuan, X.; Zhang, X.; Du, R.; Cheung, S. H.; Wei, M.; Zhou, C.; Wang, L.; Shearer, T.; Edris, B.; Smith, M.; Yao, Z.; Thant, C. N.; Rosen, N.; Luo, L.
Abstract Title: RAF dimer inhibitor lifirafenib enhances the antitumor activity of MEK inhibitor mirdametinib in RAS mutant tumors
Meeting Title: 111th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 80
Issue: 16 Suppl.
Meeting Dates: 2020 Apr 27-28/Jun 22-24
Meeting Location: Philadelphia, PA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2020-08-01
Language: English
ACCESSION: WOS:000590059307254
DOI: 10.1158/1538-7445.Am2020-6415
PROVIDER: wos
Notes: Meeting Abstract: 6415 -- Due to COVID-19 pandemic, the conference was held virtually -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Neal Rosen
    398 Rosen
  2. Zhan Yao
    37 Yao
  3. Claire Thant
    2 Thant
Related MSK Work